Literature DB >> 23036209

Greater elevation in risk for nicotine dependence per pack of cigarettes smoked among those with an anxiety disorder.

Matt G Kushner1, Kyle R Menary, Eric W Maurer, Paul Thuras.   

Abstract

OBJECTIVE: Recent work shows that the time from the initial use of nicotine, cannabis, and alcohol to the onset of dependence on these substances is shorter ("telescoped") in anxiety-disordered individuals. Previously, we hypothesized that telescoping may result from a shared neurobiology underlying both anxiety disorders and dependence. This hypothesis implies that telescoping occurs because individuals with an anxiety disorder transition to dependence with less overall drug exposure ("dependence susceptibility"). To investigate this further, we examined an estimate of the amount smoked (rather than the time transpired) from smoking initiation milestones to the onset of nicotine dependence in those with and without an anxiety disorder.
METHOD: We used the subset of respondents in the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Wave 1 who reported having smoked at least 100 cigarettes (N = 18,013). All data were based on face-to-face interviews.
RESULTS: Individuals with any anxiety disorder transitioned to nicotine dependence after smoking fewer total cigarettes than did individuals with no anxiety disorder. Furthermore, those with more than one anxiety disorder transitioned to nicotine dependence after smoking fewer cigarettes than did those with one anxiety disorder only. Several potentially confounding covariates were controlled for in these analyses.
CONCLUSIONS: Dependence susceptibility is a novel concept with the potential to inform theoretical accounts of and prevention strategies for substance dependence among those with an anxiety disorder. In addition to nicotine, our theory and past data suggest that dependence susceptibility for other addictive substances (e.g., alcohol) also would be found among those with an anxiety disorder.

Entities:  

Mesh:

Year:  2012        PMID: 23036209      PMCID: PMC3469045          DOI: 10.15288/jsad.2012.73.920

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  17 in total

1.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

Review 2.  The amygdala.

Authors:  Joseph LeDoux
Journal:  Curr Biol       Date:  2007-10-23       Impact factor: 10.834

3.  Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey.

Authors:  R C Kessler; R M Crum; L A Warner; C B Nelson; J Schulenberg; J C Anthony
Journal:  Arch Gen Psychiatry       Date:  1997-04

Review 4.  Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity.

Authors:  F Holsboer
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Bridget F Grant; Deborah S Hasin; S Patricia Chou; Frederick S Stinson; Deborah A Dawson
Journal:  Arch Gen Psychiatry       Date:  2004-11

6.  Alcohol dependence is related to overall internalizing psychopathology load rather than to particular internalizing disorders: evidence from a national sample.

Authors:  Matt G Kushner; Melanie M Wall; Robert F Krueger; Kenneth J Sher; Eric Maurer; Paul Thuras; Susanne Lee
Journal:  Alcohol Clin Exp Res       Date:  2011-09-06       Impact factor: 3.455

Review 7.  Alcoholism: allostasis and beyond.

Authors:  George F Koob
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

8.  Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Wilson M Compton; Yonette F Thomas; Frederick S Stinson; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2007-05

9.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08

10.  Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Deborah S Hasin; Frederick S Stinson; Elizabeth Ogburn; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2007-07
View more
  12 in total

Review 1.  Seventy-five years of comorbidity research.

Authors:  Matt G Kushner
Journal:  J Stud Alcohol Drugs Suppl       Date:  2014

Review 2.  Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states.

Authors:  Marina R Picciotto; Alan S Lewis; Gerrit I van Schalkwyk; Yann S Mineur
Journal:  Neuropharmacology       Date:  2015-01-09       Impact factor: 5.250

3.  Hybrid cognitive behavioral therapy versus relaxation training for co-occurring anxiety and alcohol disorder: a randomized clinical trial.

Authors:  Matt G Kushner; Eric W Maurer; Paul Thuras; Chris Donahue; Brenda Frye; Kyle R Menary; Jennifer Hobbs; Angela M Haeny; Joani Van Demark
Journal:  J Consult Clin Psychol       Date:  2012-12-31

Review 4.  The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings.

Authors:  Deborah S Hasin; Bridget F Grant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-07-26       Impact factor: 4.328

5.  Smokers with behavioral health comorbidity should be designated a tobacco use disparity group.

Authors:  Jill M Williams; Marc L Steinberg; Kim Gesell Griffiths; Nina Cooperman
Journal:  Am J Public Health       Date:  2013-07-18       Impact factor: 9.308

Review 6.  Individual differences in the behavioral effects of nicotine: A review of the preclinical animal literature.

Authors:  Adriana M Falco; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2015-09-26       Impact factor: 3.533

7.  Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments.

Authors:  Morgane Besson; Stefania Guiducci; Sylvie Granon; Jean-Philippe Guilloux; Bruno Guiard; Christelle Repérant; Philippe Faure; Stéphanie Pons; Giuseppe Cannazza; Michele Zoli; Alain M Gardier; Uwe Maskos
Journal:  Psychopharmacology (Berl)       Date:  2016-07-06       Impact factor: 4.530

Review 8.  Cognitive Dysfunction, Affective States, and Vulnerability to Nicotine Addiction: A Multifactorial Perspective.

Authors:  Morgane Besson; Benoît Forget
Journal:  Front Psychiatry       Date:  2016-09-21       Impact factor: 4.157

Review 9.  Adulthood transitions in health and welfare; a literature review.

Authors:  Berit Munck; Anita Björklund; Inger Jansson; Kristina Lundberg; Petra Wagman
Journal:  Nurs Open       Date:  2018-03-06

Review 10.  A Review of Impact of Tobacco Use on Patients with Co-occurring Psychiatric Disorders.

Authors:  Arghya Pal; Yatan Pal Singh Balhara
Journal:  Tob Use Insights       Date:  2016-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.